Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Weight-loss drugs are not linked to suicidal thoughts.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Existing drugs are being repurposed to treat cardiometabolic disorders, which is safer, faster, and cheaper than developing new drugs.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

A new compound effectively inhibits human 5α-reductase 1.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.